Jeff Yass’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.76M | Buy |
7,095
+6,117
| +625% | +$2.82M | ﹤0.01% | 5173 |
|
|
2026
Q1 | $470K | Sell |
978
-3,354
| -77% | -$1.72M | ﹤0.01% | 9837 |
|
|
2025
Q4 | $2.43M | Sell |
4,332
-1,011
| -19% | -$574K | ﹤0.01% | 5238 |
|
|
2025
Q3 | $2.75M | Sell |
5,343
-13,252
| -71% | -$5.79M | ﹤0.01% | 5156 |
|
|
2025
Q2 | $5.84M | Buy |
18,595
+1,739
| +10% | +$522K | ﹤0.01% | 3689 |
|
|
2025
Q1 | $5.14M | Buy |
16,856
+5,463
| +48% | +$1.84M | ﹤0.01% | 3597 |
|
|
2024
Q4 | $3.79M | Sell |
11,393
-13,183
| -54% | -$4.47M | ﹤0.01% | 4049 |
|
|
2024
Q3 | $8.2M | Buy |
24,576
+15,846
| +182% | +$6.02M | ﹤0.01% | 2885 |
|
|
2024
Q2 | $3.6M | Buy |
+8,730
| New | +$3.46M | ﹤0.01% | 3984 |
|
|
2024
Q1 | – | Sell |
-13,805
| Closed | -$4.85M | – | 12859 |
|
|
2023
Q4 | $4.23M | Sell |
13,805
-96,471
| -87% | -$26M | ﹤0.01% | 3997 |
|
|
2023
Q3 | $26.7M | Sell |
110,276
-35,881
| -25% | -$9.18M | 0.01% | 1481 |
|
|
2023
Q2 | $35.1M | Buy |
146,157
+131,767
| +916% | +$27.4M | 0.01% | 1231 |
|
|
2023
Q1 | $2.71M | Buy |
14,390
+12,055
| +516% | +$2.49M | ﹤0.01% | 4532 |
|
|
2022
Q4 | $496K | Sell |
2,335
-8,384
| -78% | -$1.68M | ﹤0.01% | 7894 |
|
|
2022
Q3 | $1.69M | Buy |
10,719
+6,048
| +129% | +$965K | ﹤0.01% | 5299 |
|
|
2022
Q2 | $699K | Sell |
4,671
-13,762
| -75% | -$1.99M | ﹤0.01% | 7431 |
|
|
2022
Q1 | $3.02M | Sell |
18,433
-3,622
| -16% | -$597K | ﹤0.01% | 4607 |
|
|
2021
Q4 | $4.8M | Sell |
22,055
-8,602
| -28% | -$1.8M | ﹤0.01% | 3807 |
|
|
2021
Q3 | $5.8M | Buy |
30,657
+5,545
| +22% | +$1.01M | ﹤0.01% | 3689 |
|
|
2021
Q2 | $4.44M | Sell |
25,112
-35,766
| -59% | -$6.17M | ﹤0.01% | 4247 |
|
|
2021
Q1 | $9.99M | Sell |
60,878
-12,215
| -17% | -$1.87M | ﹤0.01% | 2774 |
|
|
2020
Q4 | $10.2M | Buy |
73,093
+7,364
| +11% | +$928K | ﹤0.01% | 2477 |
|
|
2020
Q3 | $7.34M | Buy |
65,729
+36,202
| +123% | +$4.19M | ﹤0.01% | 2588 |
|
|
2020
Q2 | $2.75M | Buy |
29,527
+8,097
| +38% | +$689K | ﹤0.01% | 3952 |
|
|
2020
Q1 | $1.57M | Buy |
21,430
+1,322
| +7% | +$115K | ﹤0.01% | 4409 |
|
|
2019
Q4 | $1.69M | Sell |
20,108
-25,559
| -56% | -$1.98M | ﹤0.01% | 4595 |
|
|
2019
Q3 | $3.84M | Buy |
45,667
+12,797
| +39% | +$967K | ﹤0.01% | 3108 |
|
|
2019
Q2 | $2.15M | Buy |
+32,870
| New | +$1.89M | ﹤0.01% | 4036 |
|
|
2018
Q4 | – | Sell |
-9,003
| Closed | -$494K | – | 9552 |
|
|
2018
Q3 | $539K | Buy |
+9,003
| New | +$492K | ﹤0.01% | 6375 |
|
|
2018
Q1 | – | Sell |
-12,237
| Closed | -$447K | – | 9822 |
|
|
2017
Q4 | $444K | Buy |
12,237
+2,290
| +23% | +$80.3K | ﹤0.01% | 6855 |
|
|
2017
Q3 | $317K | Buy |
9,947
+2,347
| +31% | +$71.7K | ﹤0.01% | 7290 |
|
|
2017
Q2 | $220K | Buy |
+7,600
| New | +$213K | ﹤0.01% | 8121 |
|
Other funds holding MEDP
WA
Jeff Yass's MEDP Position: Q2 2026 in Review
Jeff Yass increased its Medpace (MEDP) stake by 625% in Q2 2026, buying an estimated $2.82M and bringing the position to 7,095 shares worth $3.76M. The position accounts for ﹤0.01% of the portfolio, ranked #5173.
Jeff Yass first reported a position in MEDP in Q2 2017 and has held it in 32 quarters since. The position peaked at $35.1M in Q2 2023. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Jeff Yass held 7,095 shares of Medpace worth $3.76M as of Q2 2026.
- Jeff Yass bought 6,117 Medpace shares in Q2 2026, an estimated $2.82M.
- Medpace made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #5173 holding.
- Jeff Yass first reported a position in Medpace in Q2 2017 and has held it in 32 quarters since.
- Jeff Yass's Medpace position peaked at $35.1M in Q2 2023.
- 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.